Furthermore, disease progression is associated with the upregulation of GAS5 and lnc-ANGPTL1-3, both located at 1q25; this finding is in line with the GEP-model for high-risk MM that is enriched in overexpressed genes mapping to chromosome 1q [27]. Here, GAS5 is linked to Miyoshi myopathy.